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Abstract
a2 macroglobulins (a2Ms) are broad-spectrum protease inhibitors that play essential roles in the innate immune system of
eukaryotic species. These large, multi-domain proteins are characterized by a broad-spectrum bait region and an internal
thioester, which, upon cleavage, becomes covalently associated to the target protease, allowing its entrapment by a large
conformational modification. Notably, a2Ms are part of a larger protein superfamily that includes proteins of the
complement system, such as C3, a multi-domain macromolecule which is also characterized by an internal thioester-
carrying domain and whose activation represents the pivotal step in the complement cascade. Recently, a2M/C3-like genes
were identified in a large number of bacterial genomes, and the Escherichia coli a2M homolog (ECAM) was shown to be
activated by proteases. In this work, we have structurally characterized ECAM by electron microscopy and small angle
scattering (SAXS) techniques. ECAM is an elongated, flexible molecule with overall similarities to C3 in its inactive form;
activation by methylamine, chymotrypsin, or elastase induces a conformational modification reminiscent of the one
undergone by the transformation of C3 into its active form, C3b. In addition, the proposed C-terminus of ECAM displays
high flexibility and different conformations, and could be the recognition site for partner macromolecules. This work sheds
light on a potential bacterial defense mechanism that mimics structural rearrangements essential for activation of the
complement cascade in eukaryotes, and represents a possible novel target for the development of antibacterials.
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Introduction
a2-macroglobulins (a2Ms) are large, multi-domain and broad-
spectrum protease inhibitors present in eukaryotes that play key
roles in host cell protection from parasitic or bacterial attack.
These proteins are characterized by a highly reactive thioester
bond as well as a bait region (Fig. 1) whose sequence is recognized
by a large spectrum of proteases. The rearrangement of a2Ms
upon cleavage of the bait region traps the attacking protease in a
cage-like structure, thus rendering proteases secreted by infecting
microorganisms ineffective, promoting efficient microbial clear-
ance. a2Ms are thus essential elements of the innate immune
system [1,2].
The a2M bait region contains recognition sites for all four
classes of proteases which, once physically entrapped, are impaired
from reaching their substrates [2]. Human a2M, specifically, is a
tetrameric 720 kDa molecule in which each 180 kDa subunit
harbors an independent bait region whose cleavage induces the
exposure and subsequent hydrolysis of a pre-concealed b-cysteinyl-
glutamyl thioester bond. This generates an irreversible conforma-
tional modification causing one or two protease molecules to
become entrapped within a cage-like structure [3,4,5,6,7,8]. This
modification also exposes the receptor-binding domain at the C-
terminus of a2M, which is subsequently recognized by cells
harboring the low density lipoprotein-related protein (LRP),
allowing clearance of a2M-protease complexes [1,2,9]. Notably,
the conformational change can also be induced in vitro through
incubation of a2M with methylamine, which directly interacts with
the thioester bond without altering the bait region [3,4,5,7,8,10]
and thus has been used extensively in the study of different forms
of a2M molecules. Small angle scattering (SAXS) studies of human
a2M revealed that the molecule becomes more compact when
reacted with proteases and after incubation with methylamine
[11,12]. In addition, low-resolution electron microscopy data is
available for a2Ms in both inactive and methylamine/protease-
activated forms [3,4,5,6,7,8,10], and very recently, a medium
resolution structure (4.3 A ˚) of the methylamine-activated human
a2M also became available [13].
Notably, a2Ms are members of the same protein superfamily as
components of the complement system, such as factor C3. In
addition to displaying regions of considerable sequence similarity,
these proteins harbor a number of homologous domains; most
family members are characterized by a conserved CxEQ motif
(Fig. 1), which forms the internal thioester bond that must become
covalently associated to target molecules in order to ensure the
protein’s biological activity [1,14,15,16]. The high-resolution
crystal structure of the 187 kDa C3 molecule reveals that it is
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that the highly reactive thioester is harbored within a protected
region in the thioester-containing domain (TED) [17,18]. The
pivotal step in the complement cascade is the activation of C3 by
proteolysis to yield C3b, in which the TED domain relocates to a
site that is 75–100 A ˚ away from its original position in C3. This
exposes the thioester to solvent, allowing it to subsequently bind
covalently to antigenic surfaces [19,20,21,22,23]; solvent-exposed
Cys and Gln residues of the TED domain are also a feature of the
human a2M [13]. It is thus evident that molecules of the a2M
superfamily must undergo major conformational changes upon
activation, and that these events are crucial for their biological
activities.
Strikingly, a2M/C3-like molecules are not limited to metazoans.
Sequence analyses of a number of bacterial genomes have recently
identified a2M-like genes in several bacteria, most of which are
pathogenic species and/or colonize higher eukaryotes [24,25].
This allowed for the identification of two classes of bacterial a2Ms,
with the most common one carrying the CxEQ motif and being
encoded by a gene that is often located juxtaposed to the one
coding for Penicillin-Binding Protein 1c (PBP1c). PBPs play key
roles in the biosynthesis of peptidoglycan, a three-dimensional
mesh that protects the bacterium from differences in osmotic
pressure and gives it its shape [26]. This observation led to the
suggestion that bacterial a2Ms could act in partnership with
PBP1c during infection, the former protecting bacteria from
proteases, the latter acting in cell wall repair upon potential
disruption of the outer membrane and destruction of the
peptidoglycan [24]. It is of note that disruption of the outer
bacterial membrane could also occur in a non-infectious context,
i.e., when members of the same bacterial community compete for
nutrients. This suggests that a2Ms could be part of a bacterial
defense mechanism. A second class of a2M, which in many species
does not carry the CxEQ motif, was also identified amongst a large
number of bacterial strains within an operon coding for four
additional lipoproteins [24], but the function of this class of
molecule is less clear.
E. coli carries both classes of a2Ms, and the mechanism of
protease inhibition through a thioester-activation mechanism [2]
was confirmed for the a2M from the PBP1c-related class. This
protein was also shown to be modifiable by methylamine and
proteases, much like eukaryotic a2M [27]. These findings
reinforced the suggestion that bacteria, much like their eukaryotic
counterparts, could employ a2M-like molecules to inhibit target
proteases, thus facilitating the infection and colonization processes
[24]. Notably, however, eukaryotic a2Ms have been reported to
exist as dimers and tetramers [2,8], whilst E. coli a2Mi sa
monomer in solution [27]. This fact could facilitate the
characterization of the bacterial form, as well as the detailed
comprehension of its functionality. However, it is unlikely that the
mechanism of protease targeting by bacterial a2Ms involves
physical entrapment, due to its monomeric nature.
Here we report the structural characterization of a2M from
Escherichia coli (henceforth called ECAM, in accordance with [27])
by small angle scattering (SAXS) and electron microscopy
techniques in both native, methylamine-treated, and protease-
activated forms. The overall shape of this monomeri a2M is highly
reminiscent of that of C3, for which a high-resolution structure is
available. Notably, SAXS experiments indicate that ECAM
changes its conformation upon reaction with methylamine,
chymotrypsin, or elastase. This modification is reminiscent of that
observed for C3 upon activation to yield C3b [19,20,21,22,23]
which exposes the thioester region. These results suggest that the
mechanism of action of bacterial a-macroglobulins could involve
recognition of proteases from the infected host, or secreted by
competing bacterial species, through steps that are associated to a
vast structural rearrangement.
Results and Discussion
Activated bacterial a2M highly resembles eukaryotic C3b
The a2M from E. coli (ECAM) is a 1653-residue molecule that
carries a signal peptide, a lipoprotein box immediately following
this sequence, and a multi-protease recognition (bait) region
Figure 1. Schematic representations of human a-macroglobulin (a2M), C3 convertase (C3), and E. coli a-macroglobulin (ECAM).
Domain assignments for a2M and C3 were based on their respective crystal structures [13,17]. Assignments for ECAM were performed with the JPRED
server, supported by the analysis performed by Doan and Gettins [27]. Note the similarity in domain predictions, including MG and TED domains. The
CLEQ sequence, a signature of the thioester bond, is present in all proteins. For simplicity, only a limited number of the domains identified or
predicted for the different molecules are depicted, and only one monomer of a2M is shown. The C-terminus of ECAM displays low sequence similarity
to that of C3 (Fig. S6).
doi:10.1371/journal.pone.0035384.g001
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embl-heidelberg.de) suggest the presence of multiple macroglob-
ulin-like (MG) domains as well as a thioester-containing domain
(TED), which are hallmarks of eukaryotic proteins of the a2M
superfamily, including the well-studied C3 molecule. In order to
obtain the first structural information of a bacterial a2M, we
expressed ECAM in its soluble form (i.e., without the signal
peptide or lipoprotein sequence) and activated it by treating with
methylamine. This procedure yielded homogeneous samples of
ECAM that were subsequently analyzed by negative staining
electron microscopy employing sodium silico tungstate (pH 7.0,
Fig. S1). In total, 51,700 individual particles were selected and
aligned against the re-projections of a 30 A ˚-filtered model of C3
(PDB coordinates 2A73). This projection matching procedure
yielded, after 50 cycles, a stable 3D model of ECAM with an
estimated resolution between 15 and 20 A ˚ (Fig. S1B). Notably, this
3D model showed clear similarities to the original images obtained
by negative staining (Fig. 2A, lines 1 and 3; compare respectively
with lines 2 and 4). In order to confirm that our 3D reconstruction
was not model-biased, we performed image analysis by a
reference-free classification (Figs. S2, S3). Comparison of the final
ECAM activated 3D structure (Fig. 2B, gray) with that of C3b,
filtered to 15 A ˚ (Fig. 2B, blue), allows for the recognition of a
number of key similarities, and one notable difference.
Methylamine-activated ECAM is an elongated molecule with
overall dimensions of 140 A ˚680 A ˚680 A ˚, thus being reminiscent
of the structure of C3b, whose dimensions are approximately
140 A ˚680 A ˚670 A ˚. Analysis of both the raw images and the re-
projections of the 3D reconstructions (Fig. 2A and S1) suggest a
molecule presenting 3 to 4 main regions of density, which could
represent groups of domains, and a considerable level of flexibility.
The latter point is also visible in the 3D models of ECAM shown
in Fig. 2B, in which the top of the ECAM structure clearly shows
two individual regions of electron density (indicated with red
arrows). It is of note that only one of these protrusions is present in
the filtered structure of C3b (blue, below); it is possible that this
region, which corresponds to the C345C domain of C3b’s a chain,
is highly flexible in ECAM, and is positioned with two different
conformations on the carbon grid, with both conformations being
detected in the final structure. Attempts to individually character-
ize the two conformations were not successful, probably due to the
relatively limited number of particles used in the 3D reconstruc-
tion (15,000). An alternative explanation to the existence of the
two protrusions would be that one of them represents an
additional domain present in ECAM but not in its eukaryotic
counterparts; this seems unlikely, since sequence comparisons do
not indicate the insertion of any large stretches of amino acids that
would be required to generate a domain of this size.
Negative staining electron microscopy experiments of the native
form were also performed, but a stable 3D model could not be
obtained, probably due to a higher flexibility than for the activated
form. Thus, in order to expand our study of the conformational
changes undertaken by a bacterial a-macroglobulin during
activation, we studied ECAM in native, methylamine-treated,
and protease-activated forms by small angle X-ray scattering
(SAXS) at physiological pH.
ECAM changes conformation upon activation
SAXS experiments were performed with four distinct samples:
native ECAM, as well as ECAM reacted with methylamine,
chymotrypsin, and elastase. All samples were purified by gel
filtration chromatography. All activated forms of ECAM migrate
faster than the native form in non-denaturing PAGE (Fig. 3A),
suggesting that activation induces a conformational change and
confirming the existence of electrophoretically ‘fast’ forms of
bacterial a2Ms [27]. Notably, the transition from ‘slow’ to ‘fast’
forms by eukaryotic a-macroglobulins results in a considerable
modification of the overall structure of the dimeric and tetrameric
molecules, revealing that the interplay between bait region and
thioester cleavage plays key roles in the induction of conforma-
tional changes [2].
Scattering patterns were recorded at different ECAM concen-
trations for all four samples and did not suggest any oligomeri-
zation or aggregation events, and are shown in Fig. 3B. The data
are represented with the form log I(s) versus s (nm
21), where I is
the measured intensity and s is the scattering angle. The intensity
curve for native ECAM (black, Fig. 3B) shows a distinct side
maximum that shifts to higher angles after the protein is reacted
with methylamine and suggests that upon activation, ECAM
undergoes a conformational change. A qualitatively similar change
was also reported for the scattering curves of native and
methylamine-treated human a2M [11], albeit on a different scale
(ECAM is a monomer and human a2M a tetramer). In the case of
the elastase or chymotrypsin-treated forms, the side maximum is
shifted towards higher angles, indicating a compactation of the
native structure, which is in agreement with the decrease of the
maximum distance (Dmax) in the p(r) plots (Fig. 3C) from 19 to
approximately 16 nm (Table 1). While the Dmax of the native and
methylamine-activated forms were similar, it follows from Fig. 3B
that the main maximum in the p(r) curve displays a shift from 5.80
for native ECAM to 5.70 nm for the methylamine-treated form.
In addition, there were significantly more differences in the range
from 10 to 15 nm in the case of the methylamine-activated form
with respect to the native form, which suggests a domain
rearrangement in line with the increase of the Rg between both
forms (Table 1). Interestingly, this change was more substantial
after incubation with proteases, where the maxima were at 5.28
and 5.25 nm for the chymotrypsin and elastase complexes,
respectively. Therefore, the modification in Dmax, the shape of
the p(r) curve and a modified Rg all point to the fact that ECAM
undergoes a conformational modification after reaction with
methylamine, and this change is even more pronounced upon its
reaction with proteases. Surprisingly, by employing fluorescence
spectroscopy, Doan and Gettins recently concluded that ECAM
does not undergo major structural modifications upon treatment
with methylamine [27]. The reasons for this discrepancy are
unclear, but the results presented here from both EM and SAXS
studies clearly show that a conformational modification occurs
upon activation.
The slow decline of the p(r) functions at large distances in all
samples might suggest that parts of the structure can adopt a
second, lowly populated conformation or structural flexibility; this
effect is most pronounced for the native and methylamine
activated forms (Fig. 3c). However, it should be noted that in
the absence of high-resolution models of ECAM our SAXS data
alone cannot provide a definitive answer. A more accurate Kratky
plot representation revealed some slight structural flexibility that is
most pronounced for the native form (Fig. S5). A potential
interpretation could be that the C-terminal domain of ECAM can
adopt several conformations in solution upon activation. This
interpretation is supported by the EM observations/comparison
with C3b (Fig. 2B) which show two potential positions for this
domain (please see below).
Conformational modifications of ECAM resemble those
of eukaryotic C3 to C3b
Using the scattering data collected on ID14-3, we initially
calculated models of native ECAM using GASBOR [28] with
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they were averaged by DAMAVER [29]. Subsequently, a refined
averaged model was calculated using GASBOR by employing a
fixed core input file calculated by DAMSTART. The envelope of
the methylamine-activated and protease-reacted forms of ECAM
(Figs. 4B, C, D) indicate a clear conformational modification,
generating a surface with a pear-like shape in all three cases.
Notably, for all three forms, the conformational change generates
Figure 2. Electron microscopy reveals that ECAM is an elongated, flexible molecule. (A) Comparison between raw images, which were
low-path filtered at 25 A ˚ (lines 1, 3) and re-projections of the obtained 3D reconstructions (lines 2, 4). (B) Isosurface representations of the 3D
reconstruction obtained for the activated form of ECAM (gray) and comparison with the 15 A ˚ filtered structure of C3b (PDB 2I07, blue). For the
isosurface representations, an averaged mass density of 0.84 Da/A ˚3 and a molecular weight value of 190 kDa were used. Black arrows represent top
(1) and bottom (2) views, while the red arrows point to the regions of potentially greatest flexibility.
doi:10.1371/journal.pone.0035384.g002
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35384Figure 3. ECAM shows a change in gel mobility and overall structure upon activation. (A) Native PAGE showing the migration profile of
ECAM. Lanes 1) native molecule; 2) methylamine-treated; 3) after reaction with chymotrypsin; 4) native molecule; 5) after reaction with porcine
pancreatic elastase (B) Small-angle X-ray scattering (SAXS) results for native, methylamine-activated, elastase- and chymotrypsin-reacted ECAM. The
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feature is reminiscent of the ‘MG key ring’ reported in structures of
C3b and other complement activation factors [19,20,21,22,23,30].
Notably, in the C3 complement system, nucleophilic activation of
the inactive thioester induces the TED and CUB domains to move
away from the MG key ring, causing the thioester to become
exposed; notably, in different structures of C3b, the final position
of the TED domain is slightly modified, with respect to the angle
that it makes with the rest of the structure [19,20,21,22,23,30].
Thus, in order to explore the possibility that modification of the
shape of ECAM from elongated into pear-like could correspond to
a conformational change involving clear movement of the TED
domain, we manually docked the structures of C3 and C3b onto
the SAXS envelopes of native ECAM and methylamine-activated
ECAM, respectively. The results are shown in Figs. 5A and 5B,
where the envelopes are displayed as a gray mesh, and the
structures of C3/C3b as blue ribbons. Results of similar structural
comparisons using the program CRYSOL [31] are shown in Fig.
S4. An initial observation that can be inferred from the
abovementioned figures is that both C3 and C3b are similar to
ECAM. Interestingly, in the native form of the molecule, one
notices additional density for ECAM in a region that corresponds
to the C-terminus of C3 (the C345C region). This extra density is
also visible in the activated form of the molecule, albeit to a lesser
extent.
The views shown in Fig. 5 strongly suggest that the modification
in the surface of the activated form of ECAM could correspond to
a change in the position of the TED domain, which, in C3b, is
located between 75 and 100 A away from its position in C3
[19,20,21,22,23]. In order to gain further insight into this
possibility, we manually fitted the structure of C3b (PDB 2I07,
as above) onto the electron microscopy 3D model of methylamine-
activated ECAM (Fig. 5C). This analysis reveals two important
points. First, it corroborates the location the TED domain (as well
as of the MG ring) in the activated form of the bacterial protein. In
addition, this analysis suggests that the C-terminal region of C3b
could be fitted into two different regions of density; only one was
modeled, but the other potential conformation of the C-terminus
of ECAM is indicated with red arrows. Thus, both SAXS and EM
techniques point to the fact that the C-terminus of ECAM is
potentially solvent-exposed and flexible. In eukaryotic a2Ms, the
C-terminal, receptor-binding domain is exposed when the
molecules are reacted with either methylamine or proteases, thus
requiring a conformational modification for solvent accessibility
[4,7,32]. This is also confirmed by the elegant docking of the
structure of C3 and C3b onto electron microscopy maps of
eukaryotic a2M, performed by Janssen and coworkers [20], as well
as the recent 4.3 A ˚ crystal structure of methylamine-activated
human a2M [13]. This suggests that proteins of the a2M family
share a number of overall structural similarities that include
overall conformational modifications upon activation. It is of
interest that inhibition of C3b by a Staphylococcal inhibitor
protein occurs through the generation of an ‘open’ conformer of
the former, which subsequently blocks formation of the C3
convertase [30], underlining the importance of complex confor-
mational changes not only for C3 function but also for its targeting
by pathogens.
The level of circulating a2M-protease complexes in humans is
low, as a consequence of the recognition of the C-terminus of a2M
by lipoprotein receptors and their subsequent internalization and
degradation. Thus, the C-terminal region of eukaryotic a2M plays
a key role in its recognition of partner macromolecules, leading to
its eventual clearance [1,2,9]. The flexible C-terminal end of
ECAM, described here, could also potentially serve as a binding
region for partners. This could include PBP1c, whose gene co-
occurs with that of a-macroglobulin in a number of bacterial
species [24]. PBP1c is a periplasmic molecule that is anchored to
the inner membrane through a single transmembrane region
[26,33]. The concerted action of PBP1c and ECAM could favor
protection of cell integrity in the presence of foreign proteases [24],
potentially through the involvement of a direct interaction
between the PBP and the C-terminal region of the a-macroglob-
ulin. This could reflect a novel bacterial defense mechanism that
implicates the action of both protease inhibition and cell wall
biosynthesis processes. On the other hand, pathogens have also
been shown to encode proteins that mimic components of the
complement system in order to manipulate the host inflammatory
response [34,35,36]; thus, due to their similarity to C3/C3b, it is
conceivable that bacterial a-macroglobulins could also play yet
undefined roles in the disruption of the complement amplification
pathway in situations where the outer cell wall is weakened. Either
one of these potential mechanisms could represent unexplored
targets for the development of novel antibacterials.
Materials and Methods
Materials
Porcine pancreatic elastase (PPE) (Fluka Biochemika) was
dissolved in 0.2 M Tris-HCl pH 8.0. HisTrap HP, Superdex
200 10/300GL and Mono Q 5/50GL columns were purchased
from GE Healthcare. Methylamine hydrochloride was obtained
from ACROS Organics.
Cloning, expression and purification of ECAM
The yfhm gene from Escherichia coli BL21 was amplified using
conventional PCR methods and subsequently cloned into pet15b
(Novagen), leading to a construct carrying a N-terminal poly-
histidine tag and residues Asp19-Pro1653 of ECAM. The plasmid
was transformed into BL21(DE3) and cells were grown in LB
broth to an OD600 nm of 0.5–0.6 and induced for 3 h at 22uC with
0.5 mM isopropyl B-D-thiogalactoside. Unless otherwise stated
buffer A (25 mM HEPES pH 7.5, 0.2 M NaCl) was used in all
radially averaged scattered X-ray intensity was plotted as a function of the momentum transfer s. Scattering patterns for ECAM in native form (black),
after reaction with methylamine (green), elastase (blue) and chymotrypsin (red) were recorded in different concentrations (from 0.5 to 8 mg/mL) but
only the curves relating to the highest concentration are shown. Inset, detail of differences in distinct side maxima. (C) Distance distributions p(r) of
native, methylamine-reacted, elastase, and chymotrypsin of ECAM. All curves were normalized. Inset, detail of maxima of p(r) functions.
doi:10.1371/journal.pone.0035384.g003
Table 1. Structural parameters calculated from the models
generated from SAXS measurements.
R(g) (nm) Dmax (nm)
SAXS
Native 4.6760.01 20.062.4
Methylamine 5.1460.03 19.061.9
Chymotrypsin 4.1460.02 16.061.9
Elastase 4.1460.01 15.062.0
doi:10.1371/journal.pone.0035384.t001
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5,000 g for 20 min at 4uC, the pellet was resuspended in buffer A
complemented with anti-proteases leupeptin (0.5 mg/mL), aproti-
nin (0.7 mg/mL), PMSF (1.0 mM) and pesptatin (0.7 mg/mL). The
lysate was obtained by sonication, centrifuged for removal of
debris at 40,000 g for 40 min (4uC), and subsequently loaded onto
a 5 mL HisTrap column in buffer A complemented with 50 mM
imidazole. Protein was eluted with a single 250 mM imidazole
step, and fractions were dialyzed overnight at 4uC against 25 mM
HEPES pH 7.5, 10 mM NaCl. ECAM-containing fractions were
subsequently loaded onto a Mono Q column equilibrated in the
dialysis buffer and eluted with a linear gradient to 0.5 M NaCl.
ECAM was further purified by gel filtration chromatography using
a Superdex 200 column equilibrated in buffer A. The central
fractions of the peak corresponding to ECAM were pooled and
concentrated to 10 mg/mL.
Preparation of activated forms of ECAM
Methylamine activation experiments were performed by
incubating pure ECAM with 200 mM methylamine hydrochloride
and 200 mM Tris-HCl pH 8.0 for 2 h at 25uC and subsequently
subjecting the sample to gel filtration chromatography as described
above. The central fractions of the peak were pooled and
concentrated to 10 mg/mL.
The reactions with elastase and chymotrypsin were carried out
using the same protocol. A 1:1 molar ratio of protease:ECAM was
Figure 4. Ab initio models of ECAM generated by SAXS. Each model results from averaging 10 individual models calculated by the program
GASBOR using: (A) native ECAM, (B) methylamine-treated, (C) chymotrypsin-treated, and (D) elastase-treated ECAM. Note the appearance of a central
cavity in all of the treated forms of the molecule. GASBOR was used in ‘‘user’’ mode, following default options, except for the total number of
residues, which corresponded to total ECAM (1653 residues). The envelopes are based on the p(r) funtions shown on Fig. 3, and the GNOM files
generated were used as input for GASBOR. The models are drawn to scale.
doi:10.1371/journal.pone.0035384.g004
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with 1 mM PMSF, and subsequently injected on a gel filtration
column; only the central fractions of the peak were used for further
experiments.
Small-angle X-ray Scattering
Measurements were recorded at the ID14-3 beamline of the
European Synchrotron Radiation Facility (Grenoble, France).
Prior to data collection a scattering curve of bovine serum albumin
Figure 5. The structures of both native and activated forms of ECAM resemble those of C3 and C3b. Surface representations of ECAM in
native (A) and methylamine-activated (B) states based on SAXS measurements. Structures of C3 (PDB 2A73) and C3b (PDB 2I07, in blue) were
modeled manually into the ECAM ab initio SAXS models. Note that the difference in position of the C3/C3b TED (thioester-containing) domain can be
well accounted for in the SAXS envelopes of both native (A) and methylamine-activated (B) forms of ECAM. (C) The X-ray structure of C3b (PDB 2I07)
was manually fitted into the 3D EM envelope of the activated ECAM. The size of the macromolecule as well as the MG ring and the TED domain are in
comparable positions. The unoccupied density, shown with red arrows, indicates the different potential position of the C-terminus domain and
indicates high flexibility in this region. The lack of sequence similarity between the C-terminal domain of ECAM and C3b (Fig. S6) could also account
for the differences observed.
doi:10.1371/journal.pone.0035384.g005
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performed at concentrations of 8.0 mg/mL for native ECAM,
6.4 mg/mL for the methylamine-activated form, 7.6 mg/mL for
elastase-incubated ECAM and 6.1 mg/mL for the chymotrypsin-
reacted ECAM. Between measurements, scattering from a buffer
sample was recorded, and these data were subsequently subtracted
from the respective sample curves. No radiation damage was
observed during the ten 10 second exposure frames and all data
were recorded at 25uC. Data were treated following default
parameters of the PRIMUS software package [37]. The radius of
gyration Rg and the forward scattering value I(0) were estimated
using the Guinier approximation [38]. Both parameters, as well
the maximum particle dimension Dmax, were also calculated by the
GNOM software [39]. Ab initio models of ECAM were generated
using GASBOR [28]. A final average model was generated from
15 independent models using DAMAVER through their pairwise
superposition [29].
Electron microscopy - Activated ECAM at a concentration
of 0.05 mg/mL was first applied to the clean side of carbon on
mica (carbon/mica interface) and negatively stained with 1% (w/
v) sodium silico tungstate [40]. A grid was placed on top of the
carbon film, and subsequently air-dried. Images were taken under
low dose conditions with a Polara microscope (FEI Eindhoven,
The Netherlands) operating at 300 kV and a nominal magnifica-
tion of 59,0006with a Gatan CCD camera (USC 4000) (pixel size
at the specimen level: 2 A ˚; defocus values ranging from 1.5 to
3 mm). A total of 51,700 particles were selected using a semi-
automatic particle selection procedure with the EMAN boxer
routine [41] and extracted into 1006100 pixel boxes. The images
were CTF-corrected with CTFFIND3 [42] and Bsoft [43] and
low-path-filtered to 25 and 10 A ˚. Due to the inherent flexibility of
ECAM, only 15,000 particles were used to calculate the final 3D
model, since the inclusion of a larger number of particles
decreased the resolution.
Image processing
A SPIDER [44]-based projection matching analysis using an
initial 3D model calculated from the related C3 structure (PDB
2A73 filtered at 30 A ˚) was performed. A total number of 800
equally spaced re-projections (5 degrees sampling) and 50 cycles
were used to obtain the final 3D reconstruction (the orientation
parameters of the raw images and 3D reconstruction were stable).
Each cycle consisted of model re-projections, alignment using the
25 A ˚ low-path-filtered stack file, and 3D reconstructions using the
10 A ˚ low-path-filtered stack file. Only the best 15,000 images
(cross correlation criteria) were used during each cycle of
projection matching. The resolution of the active form of the
ECAM was found to be between 15 and 20 A ˚ (0.3 and 0.5
Fourier-shell correlation criteria, respectively; Fig. S1B). A manual
fit the C3b convertase (pdb 2I07) was performed using PYMOL.
Reference-free image classification
Ab-initio image classification was performed by using the
IMAGIC software (ImageScience). After an initial centering step
based on the average of all images, a multivariate statistical
analysis (MSA) was performed by using a set of 69 eigen-images.
The EM raw images were divided by similarity into 150 classes
and the class averages were used to re-align/re-center the images;
the above process was iterated 3 times, resulting in the classes
presented in Fig. S2B. These classes were aligned against 196
equally distributed re-projections (every 10 degrees) of our
reconstruction (Fig. S2A). The result is show in Fig. S3. Rows
labeled 1 show the re-projections of our reconstruction whereas
rows labeled 2 show the ab initio classes averages (same images as in
panel S2b). For each re-projection, the corresponding ab inito
calculated classes are very similar, confirming our 3D reconstruc-
tion.
Supporting Information
Figure S1 A- Typical electron microscopy field of view obtained
on SST negatively stained ECAM. B- Fourier shell correlation
obtained by splitting the 15,000 images into halves in order to
calculate two independent reconstructions (Yang et al., 2003).
(JPG)
Figure S2 Comparison between equally distributed re-projec-
tions (every 10 degrees; 196) of the EM 3D reconstruction (A) and
the ab-initio obtained classes (150) (B).
(JPG)
Figure S3 Alignment of the 150 classes (Fig. S2B) against the
196 re-projections of our 3D reconstruction (Fig. S2A). The re-
projections are shown in the rows labeled ‘‘1’’, and for each re-
projection, the corresponding aligned classes are shown as a
column (part 2).
(JPG)
Figure S4 Comparison of the SAXS data for both native and
methylamine-activated ECAM with the crystal structures of C3
and C3b, respectively, using the program CRYSOL. Both fits are
relatively good at low angles, indicating that the overall shapes
(i.e., radii of gyration) are similar.
(TIF)
Figure S5 Kratky plot of SAXS experiments, which indicates
that native ECAM is the form that displays the highest amount of
flexibility.
(TIF)
Figure S6 Alignment of the C-terminal sequences of ECAM and
C3, performed with the MUSCLE server. Identical residues are
indicated with red boxes, and similar amino acids in gray. The
CxEQ motif is indicated with diamonds. The two regions display
30% sequence similarity. Reference for FigureS6: Yang S, Yu X,
Galkin VE, Egelman EH (2003). Issues of resolution and
polymorphism in singleparticle reconstruction. J. Struct. Biol.
144, 162–171.
(PDF)
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